We are live on ! Find out more
Bank Julius Baer & Co

Bank Julius Baer & Co Portfolio holdings

AUM $33.2B
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+25.01%
3 Year Est. Return
+91.4%
5 Year Est. Return
+116.23%
10 Year Est. Return
AUM
$16.1B
AUM Growth
+$358M
Cap. Flow
+$910M
Cap. Flow %
5.65%
Top 10 Hldgs %
34.97%
Holding
886
New
68
Increased
358
Reduced
361
Closed
78

Top Sells

Rank Stock Value
1
BF.B icon
Brown-Forman Class B
BF.B
+$81.2M
2
MCHI icon
iShares MSCI China ETF
MCHI
+$49.1M
3
SYF icon
Synchrony
SYF
+$41M
4
PGR icon
Progressive
PGR
+$31.9M
5
MRK icon
Merck
MRK
+$31.4M

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Healthcare 16.69%
3 Financials 12.12%
4 Communication Services 10%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEFA icon
751
iShares Core MSCI EAFE ETF
IEFA
$196B
$17K ﹤0.01%
233
+6
+3% +$456
LTRN icon
752
Lantern Pharma
LTRN
$36.5M
$17K ﹤0.01%
1,500
+473
+46% +$6.12K
NVCR icon
753
NovoCure
NVCR
$1.91B
$17K ﹤0.01%
150
+1
+0.7% +$151
PKG icon
754
Packaging Corp of America
PKG
$22.8B
$17K ﹤0.01%
121
+3
+3% +$428
XPEV icon
755
XPeng
XPEV
$11.6B
$17K ﹤0.01%
474
+24
+5% +$953
FOUR icon
756
Shift4
FOUR
$3.26B
$16K ﹤0.01%
200
+157
+365% +$13.5K
PRTS icon
757
CarParts.com
PRTS
$54.7M
$16K ﹤0.01%
+100
New +$17.4K
RH icon
758
RH
RH
$3.71B
$16K ﹤0.01%
+24
New +$16.5K
FUSN
759
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$16K ﹤0.01%
2,000
+20
+1% +$168
APA icon
760
APA Corp
APA
$13.2B
$15K ﹤0.01%
714
-2,522
-78% -$48.2K
H icon
761
Hyatt Hotels
H
$16.7B
$15K ﹤0.01%
+200
New +$15.1K
IBRX icon
762
ImmunityBio
IBRX
$8.1B
$15K ﹤0.01%
1,500
+29
+2% +$319
TXG icon
763
10x Genomics
TXG
$6.61B
$15K ﹤0.01%
100
-6,289
-98% -$1.08M
VTR icon
764
Ventas
VTR
$47.9B
$15K ﹤0.01%
+276
New +$15.8K
BCLI
765
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$14K ﹤0.01%
278
-3
-1% -$158
ACB
766
Aurora Cannabis
ACB
$185M
$13K ﹤0.01%
104
-83
-44% -$5.9K
NOC icon
767
Northrop Grumman
NOC
$81.2B
$13K ﹤0.01%
35
-270
-89% -$97.6K
PH icon
768
Parker-Hannifin
PH
$135B
$13K ﹤0.01%
2,494
+45
+2% +$13.4K
LUMN icon
769
Lumen
LUMN
$6.44B
$12K ﹤0.01%
1,001
-29
-3% -$364
YUM icon
770
Yum! Brands
YUM
$41.1B
$12K ﹤0.01%
101
-82
-45% -$10.4K
ICPT
771
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
815
+14
+2% +$224
DXJ icon
772
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
$11K ﹤0.01%
175
-5
-3% -$308
CBIO
773
Crescent Biopharma
CBIO
$626M
$11K ﹤0.01%
+50
New +$10.6K
PANW icon
774
Palo Alto Networks
PANW
$297B
$11K ﹤0.01%
147,762
+32,952
+29% +$2.32M
VDE icon
775
Vanguard Energy ETF
VDE
$9.84B
$11K ﹤0.01%
150
+5
+3% +$349

Similar funds

Bank Julius Baer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Bank Julius Baer & Co held 886 positions worth $16.1B, up 2.3% from $15.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Bank Julius Baer & Co deployed $910M of net new capital in Q3 2021, opening 68 new positions and adding to 358 existing holdings. Its largest new stake was State Street Blackstone Senior Loan ETF: 956,753 shares worth $44M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Brown-Forman Class B, an estimated $81.2M trimmed.

  • Bank Julius Baer & Co's largest Q3 2021 buy was State Street Blackstone Senior Loan ETF: 956,753 shares worth $44M.
  • Bank Julius Baer & Co added most to Microsoft in Q3 2021, an estimated $127M increase.
  • Bank Julius Baer & Co's biggest Q3 2021 reduction was Brown-Forman Class B, cutting an estimated $81.2M.
  • Bank Julius Baer & Co fully exited PhenomeX Inc. Common Stock in Q3 2021, selling an estimated $14.3M.
  • Bank Julius Baer & Co's ten largest holdings make up 35% of its $16.1B portfolio in Q3 2021.
  • Bank Julius Baer & Co opened 68 new positions and closed 78 in Q3 2021.
  • Bank Julius Baer & Co's portfolio value rose 2.3% quarter-over-quarter to $16.1B.

Based on Bank Julius Baer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.